BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38128781)

  • 1. Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis.
    Kingston R; Vella V; Pouwels KB; Schmidt JE; Abdelatif El-Abasiri RA; Reyna-Villasmil E; Hassoun-Kheir N; Harbarth S; Rodríguez-Baño J; Tacconelli E; Arieti F; Gladstone BP; de Kraker MEA; Naylor NR; Robotham JV;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S26-S36. PubMed ID: 38128781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
    Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.
    Pezzani MD; Arieti F; Rajendran NB; Barana B; Cappelli E; De Rui ME; Galia L; Hassoun-Kheir N; Argante L; Schmidt J; Rodriguez-Bano J; Harbarth S; de Kraker M; Gladstone BP; Tacconelli E
    Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S4-S13. PubMed ID: 38007387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
    European Antimicrobial Resistance Collaborators
    Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care-Associated Infections in Australia: A Retrospective Case-cohort Study.
    Lee XJ; Stewardson AJ; Worth LJ; Graves N; Wozniak TM
    Clin Infect Dis; 2021 May; 72(10):e506-e514. PubMed ID: 32822465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.
    de Kraker ME; Davey PG; Grundmann H;
    PLoS Med; 2011 Oct; 8(10):e1001104. PubMed ID: 22022233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial distribution and drug resistance in blood samples of children in Jiangxi Region, 2017-2021.
    Zhou Y; Zhou S; Peng J; Min L; Chen Q; Ke J
    Front Cell Infect Microbiol; 2023; 13():1163312. PubMed ID: 37424793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by
    Zhen X; Stålsby Lundborg C; Sun X; Hu X; Dong H
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].
    Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug-resistant organisms may be associated with bed allocation and utilization efficiency in healthcare institutions, based on national monitoring data from China (2014-2020).
    Wang XT; Meng H; Pan DF; Zheng XY; Lu WW; Chen C; Su M; Su XY; Liu Z; Ma XJ; Liang PF
    Sci Rep; 2023 Dec; 13(1):22055. PubMed ID: 38087043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the best available data to estimate the cost of antimicrobial resistance: a systematic review.
    Wozniak TM; Barnsbee L; Lee XJ; Pacella RE
    Antimicrob Resist Infect Control; 2019; 8():26. PubMed ID: 30733860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).
    Hu F; Yuan L; Yang Y; Xu Y; Huang Y; Hu Y; Ai X; Zhuo C; Su D; Shan B; Du Y; Yu Y; Lin J; Sun Z; Chen Z; Xu Y; Zhang X; Wang C; He L; Ni Y; Zhang Y; Lin D; Zhu D; Zhang Y
    Front Cell Infect Microbiol; 2022; 12():1075185. PubMed ID: 36590586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of antibiotic resistance patterns in Central Taiwan during the COVID-19 pandemic: A retrospective study.
    Tseng YW; Huang CW; Chen CC; Er TK
    J Infect Public Health; 2024 Feb; 17(2):229-235. PubMed ID: 38118294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Reg Health Am; 2023 Sep; 25():100561. PubMed ID: 37727594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.
    Zhen X; Lundborg CS; Sun X; Hu X; Dong H
    Antimicrob Resist Infect Control; 2019; 8():137. PubMed ID: 31417673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis.
    Allel K; Stone J; Undurraga EA; Day L; Moore CE; Lin L; Furuya-Kanamori L; Yakob L
    PLoS Med; 2023 Jun; 20(6):e1004199. PubMed ID: 37347726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.